Health ❯ Cancer ❯ Breast Cancer ❯ Surgery

Postoperative Care

Elutia Files 510(k) for NXT-41 as It Refocuses on Drug-Eluting Biomatrix for Breast Reconstruction

The company redirects resources to NXT-41x following a BioEnvelope sale that improved its funding.

Jessie J Cancels U.S. Tour, Pushes U.K./Europe Dates to April 2026 for Second Surgery